(JAZZ) Jazz Pharmaceuticals BollingerBands charts technical analysis
(JAZZ) Jazz Pharmaceuticals BollingerBands charts technical analysis BollingerBands analysis of Jazz Pharmaceuticals | Buy/Sell Jazz Pharmaceuticals
Jazz Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Jazz Pharmaceuticals is 760090
| Date | Closing Price | Open | High | Low | Volume |
| 06 Tue Jan 2026 | 166.99 | 173.00 | 174.10 | 162.60 | 2.685 Mn |
| 05 Mon Jan 2026 | 174.39 | 172.75 | 175.80 | 171.14 | 1.348 Mn |
| 02 Fri Jan 2026 | 173.15 | 169.50 | 174.11 | 169.26 | 0.822 Mn |
| 31 Wed Dec 2025 | 170.00 | 170.82 | 170.82 | 169.46 | 0.323 Mn |
| 30 Tue Dec 2025 | 170.82 | 170.61 | 171.66 | 169.49 | 0.669 Mn |
| 29 Mon Dec 2025 | 170.50 | 170.51 | 171.85 | 169.36 | 0.524 Mn |
| 26 Fri Dec 2025 | 170.48 | 170.93 | 170.93 | 169.22 | 0.255 Mn |
| 24 Wed Dec 2025 | 170.80 | 170.12 | 172.69 | 169.50 | 0.313 Mn |
| 23 Tue Dec 2025 | 169.47 | 168.87 | 170.22 | 168.54 | 0.468 Mn |
| 22 Mon Dec 2025 | 169.67 | 165.66 | 171.47 | 165.66 | 0.815 Mn |
Indicators analysis of Jazz Pharmaceuticals (JAZZ)
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 170.13 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
BollingerBands charts
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Jazz Pharmaceuticals ( (JAZZ) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Jazz Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Jazz Pharmaceuticals in short term but the sell signal is initial and weak.
Jazz Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Jazz Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Jazz Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 170.13 and Jazz Pharmaceuticals (JAZZ) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Jazz Pharmaceuticals (JAZZ) stock. Volume based technical analysis of Jazz Pharmaceuticals (JAZZ) stock is negative.
Jazz Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

